These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

591 related items for PubMed ID: 29482174

  • 1. Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation.
    Wang YH, Imai Y, Shiseki M, Tanaka J, Motoji T.
    Leuk Res; 2018 Apr; 67():99-108. PubMed ID: 29482174
    [Abstract] [Full Text] [Related]

  • 2. Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/β-catenin pathway.
    Zhang H, Zhang X, Wu X, Li W, Su P, Cheng H, Xiang L, Gao P, Zhou G.
    Cancer Lett; 2012 Oct 01; 323(1):106-113. PubMed ID: 22484497
    [Abstract] [Full Text] [Related]

  • 3. Knockdown of LncRNA CRNDE suppresses proliferation and P-glycoprotein-mediated multidrug resistance in acute myelocytic leukemia through the Wnt/β-catenin pathway.
    Kang Y, Zhang S, Cao W, Wan D, Sun L.
    Biosci Rep; 2020 Jun 26; 40(6):. PubMed ID: 32426817
    [Abstract] [Full Text] [Related]

  • 4. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
    Flahaut M, Meier R, Coulon A, Nardou KA, Niggli FK, Martinet D, Beckmann JS, Joseph JM, Mühlethaler-Mottet A, Gross N.
    Oncogene; 2009 Jun 11; 28(23):2245-56. PubMed ID: 19421142
    [Abstract] [Full Text] [Related]

  • 5. Suppression of multidrug resistance by rosiglitazone treatment in human ovarian cancer cells through downregulation of FZD1 and MDR1 genes.
    Zhang H, Jing X, Wu X, Hu J, Zhang X, Wang X, Su P, Li W, Zhou G.
    Anticancer Drugs; 2015 Aug 11; 26(7):706-15. PubMed ID: 26053275
    [Abstract] [Full Text] [Related]

  • 6. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
    Leith CP, Kopecky KJ, Chen IM, Eijdems L, Slovak ML, McConnell TS, Head DR, Weick J, Grever MR, Appelbaum FR, Willman CL.
    Blood; 1999 Aug 01; 94(3):1086-99. PubMed ID: 10419902
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.
    Liu YY, Gupta V, Patwardhan GA, Bhinge K, Zhao Y, Bao J, Mehendale H, Cabot MC, Li YT, Jazwinski SM.
    Mol Cancer; 2010 Jun 11; 9():145. PubMed ID: 20540746
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The clinical relevance and prognostic significance of adenosine triphosphate ATP-binding cassette (ABCB5) and multidrug resistance (MDR1) genes expression in acute leukemia: an Egyptian study.
    Farawela HM, Khorshied MM, Kassem NM, Kassem HA, Zawam HM.
    J Cancer Res Clin Oncol; 2014 Aug 11; 140(8):1323-30. PubMed ID: 24804815
    [Abstract] [Full Text] [Related]

  • 16. Dielectrophoretic Microfluidic Chip Enables Single-Cell Measurements for Multidrug Resistance in Heterogeneous Acute Myeloid Leukemia Patient Samples.
    Khamenehfar A, Gandhi MK, Chen Y, Hogge DE, Li PC.
    Anal Chem; 2016 Jun 07; 88(11):5680-8. PubMed ID: 27149245
    [Abstract] [Full Text] [Related]

  • 17. CBP-dependent Wnt/β-catenin signaling is crucial in regulation of MDR1 transcription.
    Xia Z, Guo M, Liu H, Jiang L, Li Q, Peng J, Li JD, Shan B, Feng P, Ma H.
    Curr Cancer Drug Targets; 2015 Jun 07; 15(6):519-32. PubMed ID: 25968898
    [Abstract] [Full Text] [Related]

  • 18. [Treatment outcome of multidrug resistance related mRNA expression and c-jun-N-terminal kinase activity in patients with acute myeloid leukemia].
    Do JH, Oh SH, Song EJ, Chung JS, Kang CD, Lee EY.
    Korean J Lab Med; 2007 Aug 07; 27(4):229-36. PubMed ID: 18094581
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.